Abbott’s STARLIMS LIMS technology to be installed in FDA testing laboratories
18 January 2012
The U.S. FDA will begin implementing Abbott’s STARLIMS® software-based laboratory information management system...
News
The latest news from the pharmaceutical industry. If you have a piece of news that you would like us to cover, please contact Pippa McCartney on +44(0) 1959 563311 or email us.
U.S. Food and Drug Administration approves new formulations of Viread® for use by children living with HIV
18 January 2012
Gilead Sciences, Inc. announced that the U.S. FDA has approved Viread®...
Brazil Introduces Inactivated Polio Vaccine in National Immunization Program with Sanofi Pasteur Vaccine
18 January 2012
Brazil has chosen to introduce injectable polio vaccine in its national immunization program...
Roy D. Baynes, MD, PhD, to join Gilead Sciences as Senior Vice President, Oncology Therapeutics
18 January 2012
Gilead Sciences, Inc. announced that Roy D. Baynes, MD, PhD, will join the company...
First Hepatitis C treatment data demonstrating proof of principle with direct-acting antiviral-only therapy published
18 January 2012
Full results from a Phase II clinical trial...
Daiichi Sankyo receives approval in Japan to market RANMARK®
18 January 2012
RANMARK (denosumab), a treatment for bone complications stemming from multiple myeloma and bone metastases from solid tumors...
Novartis receives approval for Lucentis® and launches Galvus® in China
18 January 2012
Novartis has received regulatory approval in China from the SFDA for Lucentis® (ranibizumab)...
Genzyme announces European approval of Framingham manufacturing plant
18 January 2012
Sanofi & Genzyme announced that the EMA has approved its manufacturing plant in Framingham....
Gilead Sciences completes acquisition of Pharmasset, Inc.
17 January 2012
Gilead Sciences, Inc. announced the completion to acquire Pharmasset, Inc...
FOSS releases new features for Vision
17 January 2012
Service Pack 7 has been released for Vision 3.50, a software package designed for use with the FOSS NIRSystems Near-Infrared laboratory and process analyzers...
Medivation and Pfizer announce results from Phase 3 Concert trial of dimebon in Alzheimer’s disease
17 January 2012
Dimebon did not meet primary efficacy endpoints...
PAT supplement
This free to view PAT supplement is sponsored by Sartorius, Extrel, ABB, Bruker Optics and FOSS NIRSystems:
Company directory
ABB Analytical Measurements | Almac | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Daltonik GmbH | CAMO Software AS | CI Precision | Cisbio Bioassays | Colder Products Company | Expo Technologies, LLC. | Freeman Technology | GE Analytical Instruments | HACH LANGE GMBH | HORIBA Scientific | Hudson Robotics, Inc. | Natoli Engineering Company, Inc. | Peter Huber Kältemaschinenbau GmbH | Randox Pharma Services | Rapid Micro Biosystems | Smithers Viscient | Synbiosis | Syngene | Watson-Marlow Pumps Group |
Login to access exclusive content